Ten-Year Experience with an Exercise-Based Outpatient Life-Style Modification Program in the Treatment of Diabetes Mellitus
- Stephen H Schneider, MD,
- Avedis K Khachadurian, MD,
- Louis F Amorosa, MD,
- Lynn Clemow, PHD and
- Neil B Ruderman, MD, PHD
- Department of Medicine, UMDNJ-Robert Wood Johnson Medical School New Brunswick, New Jersey; and the Diabetes and Metabolism Unit, Boston University School of Medicine Boston, Massachusetts
- Address Correspondence and reprint requests to Stephen H. Schneider, MD, Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition, UMDNJ-Robert Wood Johnson Medical School, One Robert Wood Johnson Place, CN 19, New Brunswick, NJ 08903-0019.
Abstract
Exercise is frequently recommended in the treatment of diabetes mellitus. Nevertheless, its use has been limited in clinical practice, and concerns about safety and efficacy persist. We have reviewed a 10-yr experience with 255 patients enrolled in a comprehensive diabetes program that emphasized physical training.
A low maximal oxygen uptake (
) was found in patients with non-insulin-dependent diabetes mellitus compared with sedentary control subjects. This was not
accounted for by autonomic neuropathy and is unlikely to be due to subtle differences in life-style. Exercise-related proteinuria
was common and occurred in 29% of patients and was associated with higher blood pressure levels at rest and during exercise,
impaired
, and decreased R-R interval variation.
Regular exercise was associated with a modest decrease in resting and exercise blood pressure. Glycosylated hemoglobin levels and plasma triglycerides improved only in patients with non-insulin-dependent diabetes mellitus. Insulin requirements were significantly reduced in patients with insulin-dependent diabetes mellitus. Compliance for up to 3 mo in the program was acceptable but longer-term compliance was poor. Serious complications during the program were rare.
Our experience suggests a program of regular aerobic training can be safely and effectively used in an outpatient population with diabetes mellitus for up to 3 mo.
- Copyright © 1992 by the American Diabetes Association











